The global fertility supplements market size is projected to reach USD 2.39 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 7.4% during the forecast period. The declining fertility rates owing to the rise in consumption of alcohol, caffeine, and cigarettes is anticipated to fuel the demand for fertility supplements.
OTC fertility supplement segment is expected to witness significant growth in emerging economies owing to the rising consumer awareness regarding the health benefits and nutritional value of these products. Self-medication, cost effectiveness, and convenience of direct purchase is expected to boost the demand of fertility supplements over the forecast period.
Factors such as growing geriatric population and rising interest for preventive healthcare have surged the demand for herbal fertility supplements, in turn spurring the growth of the fertility supplements market. Consumers are looking for ingredients such as grape seed extracts, primrose oil, and red clover in products having minimum side effects and high efficiencies. Manufacturers are focusing on providing a blend of natural and synthetic ingredients to cater to consumer demand across the globe.
Government policies like ‘one-child-per-couple’ subjected to forced sterilizations or abortions resulted in decreasing the fertility of women. However, abolishment of one and two child per couple policies and major amendments in family planning regulations are expected to have a positive effect on fertility rate. This factor is anticipated to hinder the market growth in China.
Rising number of doctors in Italy for initiating the advice for their patients to consume fertility supplements to help them to cope up with fertility issues, in combination with Rx-medicine based therapies is expected to remain a favorable factor for the market.
To request a sample copy:
https://www.grandviewresearch.com/industry-analysis/fertility-supplements-market
Further key findings from the report suggest:
- In terms of revenue, natural fertility supplements is projected to ascend at a CAGR of 8.6% over the forecast period
- Tablets and capsules segment contributed approximately over 68.7% to the total market in 2018
- Over the counter fertility supplements led the market in 2018, constituting a revenue share of over 79.3% in 2018
- Asia Pacific is expected to witness the fastest growth over the forecast period. Expansion of retail chains in countries such as India, Japan, and China has increased the dietary supplements consumption in this region
- The fertility supplements market represents a highly competitive landscape. Key players dominating the market space have been focusing on various strategic initiatives including mergers and acquisitions, product innovation, and portfolio expansion
- Key participants in the market include Fairhaven Health, Orthomol, Vitabiotics, TTK Healthcare, Lenus Pharma among others
For More Information: www.grandviewresearch.com
No comments:
Post a Comment